Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsNaveed Shams, Henk-Andre Kroon, Hisashi Kawata, Noriko Kawabata
Life of this patent
Estimating the term…
Abstract
Provided is a pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.0003 to 0.01% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino) acetate, or a salt thereof. The pharmaceutical preparation has an excellent intraocular pressure lowering effect and may be used as a therapeutic or preventive agent for glaucoma or ocular hypertension or an intraocular pressure lowering agent.
Claims15
A pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.001 to 0.003% (w/v) of isopropyl(6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof, wherein the pH of the preparation is from 4.0 to 8.0.
Dependencies are inferred from the claim text.